Replimune Group, Inc. (REPL)

8.07 +1.03 (+14.63%) USD  |  NASDAQ  |  Mar 06, 16:00
9.21 +1.14 (+14.13%) After-Hours: 20:00
More

Replimune Group Gain (Loss) on Investment Securities (Quarterly)

Gain (Loss) on Investment Securities (Quarterly) Chart

View Gain (Loss) on Investment Securities (Quarterly) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gain (Loss) on Investment Securities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Gain (Loss) on Investment Securities (Quarterly) Range, Past 5 Years

View Gain (Loss) on Investment Securities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gain (Loss) on Investment Securities (Quarterly) Benchmarks

View Gain (Loss) on Investment Securities (Quarterly) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. --
Sarepta Therapeutics, Inc. Upgrade
REGENXBIO, Inc. --
Bristol Myers Squibb Co. --
Mirum Pharmaceuticals, Inc. --